|
|
|
|
|
|
|
SIZE:
|
|
|
|
GENERIC NAME:
|
|
|
|
MANUFACTURER:
|
|
|
|
UNIT:
|
|
|
|
ADMINISTRATION ROUTE:
|
|
|
|
FDA PREGNANCY GROUP:
|
|
B
|
|
INDICATIONS:
|
|
Anesthesia, infiltration |
|
Anesthesia, local |
|
Anesthesia, regional |
|
Anesthesia, topical |
| |
|
|
SIDE EFFECTS:
|
|
Angioedema |
|
dermatitis, contact |
|
|
ABSOLUTE
CONTRAINDICATIONS :
|
|
|
|
RELATIVE
CONTRAINDICATIONS : |
|
Local infection at site of application |
|
Sensitivity to the topical anesthetic being considered for use or to chemically related anesthetics and, for the ester derivatives, to PABA, parabens |
|
Sensitivity to other ingredients in the formulation |
|
Skin disorders, severe or extensive, especially if skin is abraded or broken |
|
|
ADULT DOSE:
|
|
Anesthetic, local-Topical, as a 5% ointment, to the affected area three or four times a day as needed. |
|
MAXIMUM ADULT DOSE:
|
|
|
|
PEDIATRIC DOSE:
|
|
Anesthetic, local-Children up to 2 years of age: Dosage has not been established.
Children 2 years of age and older: See Usual adult and adolescent dose. |
|
MAXIMUM PEDIATRIC
DOSE:
|
|
|
|
ELDERLY DOSE:
|
|
|
|
|
|
|
|